Stress Response Using Thin and Standard Size Endoscopy.

Sponsor
Hvidovre University Hospital (Other)
Overall Status
Terminated
CT.gov ID
NCT00273130
Collaborator
(none)
60
1
41
1.5

Study Details

Study Description

Brief Summary

Sixty patients scheduled for upper diagnostic gastroscopy were randomised after written informed consent into three groups.

  1. transnasal gastroscopy with thin endoscope

  2. transoral with thin endoscope

  3. standard size trans-oral endoscopy Stress response parameters (epinephrine, nor-epinephrine and cortisol, heartrate variability data and pulse oximetry data were monitored.

Condition or Disease Intervention/Treatment Phase
  • Procedure: transnasal endoscopy
  • Procedure: transoral thin endoscopy
Phase 2/Phase 3

Detailed Description

A substantial number of descriptive studies and clinical trials have made it evident that upper gastrointestinal endoscopy elicits cardiovascular and respiratory changes. Recent publications have indicated less marked cardiovascular changes when using thinner endoscopes or transnasal endoscopy .Hormonal stress response during upper gastrointestinal endoscopy has also been described, but never related to the different methods of upper gastrointestinal endoscopy. Furthermore the patient tolerance is markedly improved compared to the standard transoral route.

The aim of the present randomised study was to evaluate the ECG-, blood pressure- and pulse rate changes and the endocrine stress response (norepinephrine, epinephrine and cortisol) elicited by upper gastrointestinal endoscopy using a thin endoscope either transnasally or orally or a standard endoscope orally.

Method and material Sixty patients were included consecutively after written and informed consent and were all over 18 years. Patients receiving digitalis, ß-blocking agents or calcium antagonists were excluded, as well as patients receiving drugs for thyroid dysfunction or patients receiving steroids. Patients with known disease or trauma of the nasal cavity were not included.

Only intended diagnostic upper gastrointestinal endoscopies were included. The patients received standard medication during the endoscopy if required.

Immediately prior to the endoscopy each of the 60 patients chose an envelope with the allocation to one of three groups A) Endoscopy with a thin endoscope (4.5 mm Olympus prototype fiberendoscope) introduced transnasally (T group), B) Endoscopy with a thin endoscope (4.5 mm Olympus prototype fiberendoscope) introduced orally (O group) or C) Endoscopy with a standard gastroscope (6 mm Olympus GIF XV10) (S group). All patients received the same amount of a local anesthetic spray (Lidocaine 10 mg/dose, ASTRA Zeneca) (twice in each nostril and twice in the oropharynx, given by one of two particular persons to ensure application of comparable doses of local anesthetic).

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Randomised Evaluation of Neuroendocrine Stress Response During Upper Gastrointestinal Endoscopy With Standard or Ultrathin Endoscope.
Study Start Date :
Mar 1, 1999
Study Completion Date :
Aug 1, 2002

Outcome Measures

Primary Outcome Measures

  1. tachycardia, ischaemia, level of stress response []

Secondary Outcome Measures

  1. acceptability of transnasal endoscopy []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • diagnostic gastroscopy, age over 18, danish speaking,
Exclusion Criteria:
  • use of beta blocking or any other heart rate modulating drug, antithyroid drugs

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hvidovre University Hospital, Dept of Surgery Hvidovre Denmark 2650

Sponsors and Collaborators

  • Hvidovre University Hospital

Investigators

  • Principal Investigator: Merete Christensen, MD, Dept of Cardiothoracic Surgery, Copenhagen University Hospital, Rigshospitalet, Copenhagen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00273130
Other Study ID Numbers:
  • MC-01-KAT
  • KF01-245/97
First Posted:
Jan 9, 2006
Last Update Posted:
Sep 13, 2006
Last Verified:
Dec 1, 2003

Study Results

No Results Posted as of Sep 13, 2006